Mental health and chemical dependency services at US transplant centers

Shehzad K. Niazi, Aaron Spaulding, Emily Vargas, Terry Schneekloth, Julia Crook, Teresa Rummans, C. Burcin Taner

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to assess the availability of mental health (MH) and chemical dependency (CD) services at US transplant centers, because appropriate psychosocial assessment and care is associated with better transplant outcomes. We used the 2017-2018 American Hospital Association survey, Area Health Resource File, and Centers for Medicare & Medicaid Services Hospital Compare databases to quantify availability of services and examined associations of hospital- and health services area-level characteristics with odds of offering services with generalized linear mixed models. We found that 15% of transplant centers did not offer MH services and 62% did not offer CD services. Hospitals were more likely to offer MH services if they were larger (OR [95% CI]: 1.03 [1.01, 1.06]) and had a lower rate of uninsured patients in the health services area (OR [95% CI]: 0.89 [0.80, 0.99]) and were more likely to offer CD services if they were larger (OR [95% CI]: 1.02 [1.01, 1.03]) or were members of a system (OR [95% CI]: 2.31 [1.26, 4.24]). Additional research is needed to understand whether lack of MH or CD services at transplant centers affects patients’ ability to access comprehensive psychosocial care and whether this affects patient outcomes.

Original languageEnglish (US)
JournalAmerican Journal of Transplantation
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Mental Health
Catchment Area (Health)
Transplants
Mental Health Services
American Hospital Association
Aptitude
Health Resources
Medicaid
Medicare
Linear Models
Databases
Dependency (Psychology)
Research

Keywords

  • ethics and public policy
  • health services and outcomes research
  • mental health
  • organ transplantation in general
  • quality of care/care delivery
  • quality of life

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Mental health and chemical dependency services at US transplant centers. / Niazi, Shehzad K.; Spaulding, Aaron; Vargas, Emily; Schneekloth, Terry; Crook, Julia; Rummans, Teresa; Taner, C. Burcin.

In: American Journal of Transplantation, 01.01.2019.

Research output: Contribution to journalArticle

Niazi, Shehzad K. ; Spaulding, Aaron ; Vargas, Emily ; Schneekloth, Terry ; Crook, Julia ; Rummans, Teresa ; Taner, C. Burcin. / Mental health and chemical dependency services at US transplant centers. In: American Journal of Transplantation. 2019.
@article{39713e8316164697860386c154f58360,
title = "Mental health and chemical dependency services at US transplant centers",
abstract = "The purpose of this study was to assess the availability of mental health (MH) and chemical dependency (CD) services at US transplant centers, because appropriate psychosocial assessment and care is associated with better transplant outcomes. We used the 2017-2018 American Hospital Association survey, Area Health Resource File, and Centers for Medicare & Medicaid Services Hospital Compare databases to quantify availability of services and examined associations of hospital- and health services area-level characteristics with odds of offering services with generalized linear mixed models. We found that 15{\%} of transplant centers did not offer MH services and 62{\%} did not offer CD services. Hospitals were more likely to offer MH services if they were larger (OR [95{\%} CI]: 1.03 [1.01, 1.06]) and had a lower rate of uninsured patients in the health services area (OR [95{\%} CI]: 0.89 [0.80, 0.99]) and were more likely to offer CD services if they were larger (OR [95{\%} CI]: 1.02 [1.01, 1.03]) or were members of a system (OR [95{\%} CI]: 2.31 [1.26, 4.24]). Additional research is needed to understand whether lack of MH or CD services at transplant centers affects patients’ ability to access comprehensive psychosocial care and whether this affects patient outcomes.",
keywords = "ethics and public policy, health services and outcomes research, mental health, organ transplantation in general, quality of care/care delivery, quality of life",
author = "Niazi, {Shehzad K.} and Aaron Spaulding and Emily Vargas and Terry Schneekloth and Julia Crook and Teresa Rummans and Taner, {C. Burcin}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/ajt.15659",
language = "English (US)",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Mental health and chemical dependency services at US transplant centers

AU - Niazi, Shehzad K.

AU - Spaulding, Aaron

AU - Vargas, Emily

AU - Schneekloth, Terry

AU - Crook, Julia

AU - Rummans, Teresa

AU - Taner, C. Burcin

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The purpose of this study was to assess the availability of mental health (MH) and chemical dependency (CD) services at US transplant centers, because appropriate psychosocial assessment and care is associated with better transplant outcomes. We used the 2017-2018 American Hospital Association survey, Area Health Resource File, and Centers for Medicare & Medicaid Services Hospital Compare databases to quantify availability of services and examined associations of hospital- and health services area-level characteristics with odds of offering services with generalized linear mixed models. We found that 15% of transplant centers did not offer MH services and 62% did not offer CD services. Hospitals were more likely to offer MH services if they were larger (OR [95% CI]: 1.03 [1.01, 1.06]) and had a lower rate of uninsured patients in the health services area (OR [95% CI]: 0.89 [0.80, 0.99]) and were more likely to offer CD services if they were larger (OR [95% CI]: 1.02 [1.01, 1.03]) or were members of a system (OR [95% CI]: 2.31 [1.26, 4.24]). Additional research is needed to understand whether lack of MH or CD services at transplant centers affects patients’ ability to access comprehensive psychosocial care and whether this affects patient outcomes.

AB - The purpose of this study was to assess the availability of mental health (MH) and chemical dependency (CD) services at US transplant centers, because appropriate psychosocial assessment and care is associated with better transplant outcomes. We used the 2017-2018 American Hospital Association survey, Area Health Resource File, and Centers for Medicare & Medicaid Services Hospital Compare databases to quantify availability of services and examined associations of hospital- and health services area-level characteristics with odds of offering services with generalized linear mixed models. We found that 15% of transplant centers did not offer MH services and 62% did not offer CD services. Hospitals were more likely to offer MH services if they were larger (OR [95% CI]: 1.03 [1.01, 1.06]) and had a lower rate of uninsured patients in the health services area (OR [95% CI]: 0.89 [0.80, 0.99]) and were more likely to offer CD services if they were larger (OR [95% CI]: 1.02 [1.01, 1.03]) or were members of a system (OR [95% CI]: 2.31 [1.26, 4.24]). Additional research is needed to understand whether lack of MH or CD services at transplant centers affects patients’ ability to access comprehensive psychosocial care and whether this affects patient outcomes.

KW - ethics and public policy

KW - health services and outcomes research

KW - mental health

KW - organ transplantation in general

KW - quality of care/care delivery

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=85075727901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075727901&partnerID=8YFLogxK

U2 - 10.1111/ajt.15659

DO - 10.1111/ajt.15659

M3 - Article

C2 - 31612625

AN - SCOPUS:85075727901

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

ER -